LYNETTE ELKINS: Open Payments
NPI 1366987208 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 71 payments from 14 companies in 2025. Trend: 2023 $1,259 · 2024 $1,197 · 2025 $1,265
Food & beverage: $1,265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $388 |
| Janssen Biotech, Inc. | 11 | $211 |
| Madrigal Pharmaceuticals | 6 | $142 |
| Ardelyx, Inc. | 4 | $91 |
| GENZYME CORPORATION | 3 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| Aimmune Therapeutics, Inc. | 3 | $63 |
| Gilead Sciences, Inc. | 2 | $34 |
| Braintree Laboratories, Inc. | 2 | $32 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, DUPIXENT, IBSRELA, VIBERZI, CREON, IQIRVO.
Industry payments across AL — which companies pay providers there.
